Immunogenicity 12767
Sample ID
3998
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CSNK1G2
Transcript ID
uc010dsu.3
HLA INFO
B*15:01
TCR INFO
No TCR info found!
Full length protein sequence (367 aa)
MDRWM
1
VAVRM
6
DRVAG
11
KNLYT
16
NEYVA
21
IKLEP
26
IKSRA
31
PQLHL
36
EYRFY
41
KQLSA
46
TEGVP
51
QVYYF
56
GPCGK
61
YNAMV
66
LELLG
71
PSLED
76
LFDLC
81
DRTFT
86
LKTVL
91
MIAIQ
96
LITRM
101
EYVHT
106
KSLIY
111
RDVKP
116
ENFLV
121
GRPGT
126
KRQHA
131
IHIID
136
FGLAK
141
EYIDP
146
ETKKH
151
IPYRE
156
HKSLT
161
GTARY
166
MSINT
171
HLGKE
176
QSRRD
181
DLEAL
186
GHMFM
191
YFLRG
196
SLPWQ
201
GLKAD
206
TLKER
211
YQKIG
216
DTKRA
221
TPIEV
226
LCENF
231
PEEMA
236
TYLRY
241
VRRLD
246
FFEKP
251
DYDYL
256
RKLFT
261
DLFDR
266
SGFVF
271
DYEYD
276
WAGKP
281
LPTPI
286
GTVHT
291
DLPSQ
296
PQLRD
301
KTQPH
306
SKNQA
311
LNSTN
316
GELNA
321
DDPTA
326
GHSNA
331
PITAP
336
AEVEV
341
ADETK
346
CCCFF
351
KRRKR
356
KSLQR
361
HK
366
Mutation Information
DNA mutation:
None
Peptide Range:
316 ~ 340
Mut AA position:
328 (13 in Wild Type peptide)
Alignment
Wild Type:
"LNSTNGELNADDPTAGHSNAPITAP
||||||||||||.||||||||||||
Mutant:
LNSTNGELNADDSTAGHSNAPITAP"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CSNK1G2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
COS7
Assay
IFNg ELISPOT assay